BioSpace News Archive

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced it has met the safety requirements for the first 12 participants in its Phase Ib human adenovirus (hAd5)-based T-cell COVID-19 vaccine trials in sublingual and oral formulations

The U.S. Department of Labor has approved the creation of a modern apprenticeship program for prospective biomedical equipment technicians.

Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced the closing of its previously announced underwritten public offering of 57,479,978 shares of its common stock, including 11,694,150 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares, at a price to the public of $1.45 per share.

The Centre for Disease Control and Prevention has declared insufficient sleep a ‘public health problem’, with more than one-third of American adults not getting enough sleep on a regular basis.